Skip to main content

Table 2 Summary of PRMT5 scoring distribution

From: Targeting protein arginine methyltransferase 5 inhibits human hepatocellular carcinoma growth via the downregulation of beta-catenin

Composite score

Normal liver tissue (n = 54)

HCC tissue (n = 54)

<2 (weak immunopositivity)

28 (51.9 %)

5 (9.3 %)

2–4 (moderate immunopositivity)

22 (40.7 %)

18 (33.3 %)

≥4 (strong immunopositivity)

4 (7.4 %)

31 (57.4 %)

P values

 

<0.0001

  1. P value calculated by χ 2 test for normal liver tissue versus HCC tissue
Back to article page

Journal of Translational Medicine

ISSN: 1479-5876

Contact us